Market Overview:
The global cellular health screening/health testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of chronic diseases, rising awareness about preventive healthcare, and technological advancements in cellular health screening/health testing devices. Based on type, the global cellular health screening/health testing market is segmented into single test and multitest. The multitest segment is expected to grow at a higher CAGR than the single test segment during the forecast period. This growth can be attributed to the increasing demand for comprehensive tests that can provide detailed information about an individual’s overall health status. Based on application, the global cellular health screening/health testing market is divided into hospital and diagnostic labs segments. The hospital segment accounted for a larger share of the global market in 2017 owing to rising demand for early diagnosis and treatment of chronic diseases among patients worldwide.
Product Definition:
Cellular health screening/health testing is a way to assess the general health of cells. The importance of cellular health screening/health testing is that it can help identify potential problems with cells before they cause more serious issues.
Single Test:
Single test is a term used for testing of any analyte in the blood. It can be used to diagnose or detect any disease or health condition. The most common tests are cholesterol, sugar, and blood pressure tests that are conducted on all patients before starting any treatment/surgeries.
Multitest:
Multitest is a technique used in molecular diagnostics for the detection of several infectious diseases and medical conditions. It involves the use of more than one test to detect various pathogens or disease-causing agents. The tests are performed simultaneously, and results are compared to give out a positive or negative result regarding presence/absence of certain disease-causing agents.
Application Insights:
The hospital application segment accounted for the largest revenue share in 2017. The growth is attributed to the rising prevalence of chronic diseases, such as cancer, diabetes and cardiovascular diseases. In addition, an increase in the number of surgeries has also positively influenced segment growth.
Diagnostic Labs are anticipated to be the fastest-growing segment over the forecast period owing to factors such as increasing demand for point-of-care diagnostic tests and technological advancements that have led to a reduction in test costs and time required for assay processing. For instance, according to a study published by NCBI in 2018; it was found that R&D investments pertainingto rapid diagnostic tests have increased from USD 200 millionin 2013 till 2015 to USD 810 million from 2015 till 2020 during which period there wasa rise of around 35% in overall investment spending on diagnostics researchand development across all countries globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and favorable reimbursement policies & regulatory reforms in this region. For instance, as per a recent study by Mckinsey & Company, healthcare expenditure will increase by USD X trillion over the next decade due to rising prevalence of chronic diseases like cancer and diabetes. Moreover, according to an article published in The Atlantic magazine titled ‘The High Cost Of Untapped Potential’ chronic disease accounts for nearly 50% deaths among Americans every year which amounts approximately 13 million deaths annually or 27% mortality rate amongst adults (over 35 years) alone.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits of people. According to a study by the World Health Organization (WHO), non-communicable diseases are responsible for over 63% of all deaths worldwide. This number is expected to increase in the coming years due to the rising population and aging population. Thus, there is a growing demand for preventive health screenings that can help identify early signs and symptoms of these diseases.
- Growing awareness about preventive health screenings: There has been a growing awareness among people about the importance of preventive health screenings in recent years. This has led to an increase in demand for such services across different geographies. In addition, there has been an increasing trend among people towards self-monitoring their health status through home-based tests and screening kits.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cellular Health Screening/Health Testing Market Research Report
By Type
Single Test, Multitest
By Application
Hospital, Diagnostic Labs
By Companies
Telomere Diagnostics, Inc.(TDX), Spectracell Laboratories, Life Length, Repeat Diagnostics Inc.(Repeat DX), Titanovo, Cell Science Systems, Quest Diagnostics, Labcorp Holdings, Biorefrence Laboratories, Cleveland Heartlab, Inc., Genova Diagnostics, Zimetry LLC, Immundiagnostik AG, Segterra, Inc., DNA Labs India
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Cellular Health Screening/Health Testing Market Report Segments:
The global Cellular Health Screening/Health Testing market is segmented on the basis of:
Types
Single Test, Multitest
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Diagnostic Labs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Telomere Diagnostics, Inc.(TDX)
- Spectracell Laboratories
- Life Length
- Repeat Diagnostics Inc.(Repeat DX)
- Titanovo
- Cell Science Systems
- Quest Diagnostics
- Labcorp Holdings
- Biorefrence Laboratories
- Cleveland Heartlab, Inc.
- Genova Diagnostics
- Zimetry LLC
- Immundiagnostik AG
- Segterra, Inc.
- DNA Labs India
Highlights of The Cellular Health Screening/Health Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Test
- Multitest
- By Application:
- Hospital
- Diagnostic Labs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cellular Health Screening/Health Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cellular health screening/health testing is a process of evaluating the overall health of cells in an individual. Cellular health screenings can include assessments for cancer, heart disease, diabetes, and other chronic conditions.
Some of the major companies in the cellular health screening/health testing market are Telomere Diagnostics, Inc.(TDX), Spectracell Laboratories, Life Length, Repeat Diagnostics Inc.(Repeat DX), Titanovo, Cell Science Systems, Quest Diagnostics, Labcorp Holdings, Biorefrence Laboratories, Cleveland Heartlab, Inc., Genova Diagnostics, Zimetry LLC, Immundiagnostik AG, Segterra, Inc., DNA Labs India.
The cellular health screening/health testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cellular Health Screening/Health Testing Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cellular Health Screening/Health Testing Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cellular Health Screening/Health Testing Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cellular Health Screening/Health Testing Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cellular Health Screening/Health Testing Market Size & Forecast, 2018-2028 4.5.1 Cellular Health Screening/Health Testing Market Size and Y-o-Y Growth 4.5.2 Cellular Health Screening/Health Testing Market Absolute $ Opportunity
Chapter 5 Global Cellular Health Screening/Health Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cellular Health Screening/Health Testing Market Size Forecast by Type
5.2.1 Single Test
5.2.2 Multitest
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cellular Health Screening/Health Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cellular Health Screening/Health Testing Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Diagnostic Labs
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cellular Health Screening/Health Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cellular Health Screening/Health Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cellular Health Screening/Health Testing Analysis and Forecast
9.1 Introduction
9.2 North America Cellular Health Screening/Health Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cellular Health Screening/Health Testing Market Size Forecast by Type
9.6.1 Single Test
9.6.2 Multitest
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cellular Health Screening/Health Testing Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Diagnostic Labs
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cellular Health Screening/Health Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Cellular Health Screening/Health Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cellular Health Screening/Health Testing Market Size Forecast by Type
10.6.1 Single Test
10.6.2 Multitest
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cellular Health Screening/Health Testing Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Diagnostic Labs
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cellular Health Screening/Health Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cellular Health Screening/Health Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cellular Health Screening/Health Testing Market Size Forecast by Type
11.6.1 Single Test
11.6.2 Multitest
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cellular Health Screening/Health Testing Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Diagnostic Labs
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cellular Health Screening/Health Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Cellular Health Screening/Health Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cellular Health Screening/Health Testing Market Size Forecast by Type
12.6.1 Single Test
12.6.2 Multitest
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cellular Health Screening/Health Testing Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Diagnostic Labs
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cellular Health Screening/Health Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cellular Health Screening/Health Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cellular Health Screening/Health Testing Market Size Forecast by Type
13.6.1 Single Test
13.6.2 Multitest
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cellular Health Screening/Health Testing Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Diagnostic Labs
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cellular Health Screening/Health Testing Market: Competitive Dashboard
14.2 Global Cellular Health Screening/Health Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Telomere Diagnostics, Inc.(TDX)
14.3.2 Spectracell Laboratories
14.3.3 Life Length
14.3.4 Repeat Diagnostics Inc.(Repeat DX)
14.3.5 Titanovo
14.3.6 Cell Science Systems
14.3.7 Quest Diagnostics
14.3.8 Labcorp Holdings
14.3.9 Biorefrence Laboratories
14.3.10 Cleveland Heartlab, Inc.
14.3.11 Genova Diagnostics
14.3.12 Zimetry LLC
14.3.13 Immundiagnostik AG
14.3.14 Segterra, Inc.
14.3.15 DNA Labs India